What is the global market size of Sepsis Diagnostics Market?

Global Sepsis Diagnostics Market size was valued at USD 0.59 billion in 2021 and is poised to grow from USD 0.67 billion in 2022 to USD 1.30 billion by 2030, growing at a CAGR of 9.8% during the forecast period (2023-2030).

What is the key driver of Global Sepsis Diagnostics Market?

Rising incidence of hospital-acquired infections: The increasing occurrence of hospital-acquired infections (HAIs), commonly referred to as nosocomial infections, represents a significant global health concern. Among the most prevalent HAIs are urinary tract infections, pneumonia, and sepsis. These infections can have particularly severe consequences in vulnerable patient populations, including those who are immunocompromised, elderly, or suffering from chronic illnesses. In the United States, there is a troubling trend of rising sepsis incidence among hospitalized patients, with an annual increase of 8.7%. It is estimated that the United States witnesses over 1,000,000 cases of sepsis among hospitalized patients each year, as reported by the Centers for Disease Control and Prevention (CDC) in 2018. Given the rapid escalation of HAIs on a global scale, there is a heightened demand anticipated for sepsis diagnostic products in the years ahead.

Sepsis Diagnostics Market Size, Share, Growth Analysis, By Technology(Blood Culture Technology and Immunoassays), By Application(Hospitals and Diagnostics Centres) - Industry Forecast 2024-2031

Q: What is the key market trend for Global Sepsis Diagnostics Market?

One of the key market trends in the global sepsis diagnostic market is the increasing adoption of point-of-care (POC) testing. POC tests are designed to provide rapid and accurate diagnosis of sepsis, which can significantly improve patient outcomes. POC tests are portable, easy-to-use, and can be conducted outside the traditional laboratory setting, making them ideal for use in emergency rooms, ambulances, and critical care units. The demand for POC tests is expected to increase over the forecast period, driven by the need for rapid diagnosis and the growing adoption of digital health technologies.

Report ID: SQMIG35A2237 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 59 | Figures: 75

Sepsis Diagnostics Market Competitive Landscape

The global sepsis diagnostic market is highly competitive, with several established players competing for market share. These companies are investing heavily in R&D activities to develop technologically advanced diagnostic solutions and gain a competitive edge. Moreover, strategic partnerships and collaborations with other companies and healthcare facilities are commonly observed in the market. Additionally, companies are focusing on expanding their geographic presence through acquisitions, partnerships, and collaborations. Furthermore, product launches, regulatory approvals, and patent filings are among the key strategies adopted by companies to strengthen their market position.

Top Player’s Company Profiles in Global Sepsis Diagnostics Market

Abbott Laboratories (US)

Becton, Dickinson and Company (US)

bioMérieux SA (France)

Cepheid (US)

F. Hoffmann-La Roche AG (Switzerland)

Hologic Inc. (US)

Imbio LLC (US)

Luminex Corporation (US)

MedMira Inc. (Canada)

Meridian Bioscience, Inc. (US)

Nanosphere (US)

QIAGEN N.V. (Netherlands)

Thermo Fisher Scientific Inc. (US)

T2 Biosystems, Inc. (US)

Biomarck Pharmaceuticals Ltd. (UK)

Magnitude Biosciences (US)

Axis-Shield Diagnostics Ltd. (UK)

Biocartis Group NV (Belgium)

Inflammatix Inc. (US)

OpGen, Inc. (US)

Global Sepsis Diagnostics Market

Sepsis Diagnostics Market Report Snapshots

Global Sepsis Diagnostics Companies

Global Sepsis Diagnostics Market Size

Global Sepsis Diagnostics Market Analysis

Global Sepsis Diagnostics Geographic Analysis

Global Sepsis Diagnostics Market News

License Type

File Type

$5,300
BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION

What is the market size of Sepsis Diagnostics Market?

Sepsis Diagnostics Market size was valued at USD 0.67 billion in 2022 and is poised to grow from USD 0.74 billion in 2023 to USD 1.55 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2024-2031).

Who are the key vendors in the Sepsis Diagnostics Market?

The sepsis diagnostic market is highly competitive, with several established players competing for market share. These companies are investing heavily in R&D activities to develop technologically advanced diagnostic solutions and gain a competitive edge. Moreover, strategic partnerships and collaborations with other companies and healthcare facilities are commonly observed in the market. Additionally, companies are focusing on expanding their geographic presence through acquisitions, partnerships, and collaborations. Furthermore, product launches, regulatory approvals, and patent filings are among the key strategies adopted by companies to strengthen their market position. 'Abbott Laboratories (US)', 'Becton, Dickinson and Company (US)', 'bioMérieux SA (France)', 'Cepheid (US)', 'F. Hoffmann-La Roche AG (Switzerland)', 'Hologic Inc. (US)', 'Imbio LLC (US)', 'Luminex Corporation (US)', 'MedMira Inc. (Canada)', 'Meridian Bioscience, Inc. (US)', 'Nanosphere (US)', 'QIAGEN N.V. (Netherlands)', 'Thermo Fisher Scientific Inc. (US)', 'T2 Biosystems, Inc. (US)', 'Biomarck Pharmaceuticals Ltd. (UK)', 'Magnitude Biosciences (US)', 'Axis-Shield Diagnostics Ltd. (UK)', 'Biocartis Group NV (Belgium)', 'Inflammatix Inc. (US)', 'OpGen, Inc. (US)'

What is the key market trend for Sepsis Diagnostics Market?

One of the key market trends in the sepsis diagnostic market is the increasing adoption of point-of-care (POC) testing. POC tests are designed to provide rapid and accurate diagnosis of sepsis, which can significantly improve patient outcomes. POC tests are portable, easy-to-use, and can be conducted outside the traditional laboratory setting, making them ideal for use in emergency rooms, ambulances, and critical care units. The demand for POC tests is expected to increase over the forecast period, driven by the need for rapid diagnosis and the growing adoption of digital health technologies.

Which region accounted for the largest share in Sepsis Diagnostics Market?

North America dominated the sepsis diagnostic market due to the increasing incidence of sepsis and hospital-acquired infections, coupled with the presence of leading market players and advanced healthcare infrastructure. The US and Canada are the major contributors to the growth of the market in this region. In addition, the increasing awareness about sepsis and the availability of advanced diagnostic solutions are also driving the growth of the market in North America.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Sepsis Diagnostics Market Size, Share, Growth Analysis, By Technology(Blood Culture Technology and Immunoassays), By Application(Hospitals and Diagnostics Centres) - Industry Forecast 2024-2031

Sepsis Diagnostics Market Competitive Landscape

Sepsis Diagnostics Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Sepsis Diagnostics Market Size, Share, Growth Analysis, By Technology(Blood Culture Technology and Immunoassays), By Application(Hospitals and Diagnostics Centres) - Industry Forecast 2024-2031

Sepsis Diagnostics Market Competitive Landscape

Sepsis Diagnostics Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Sepsis Diagnostics Market?

Who are the key vendors in the Sepsis Diagnostics Market?

What is the key driver of Sepsis Diagnostics Market?

What is the key market trend for Sepsis Diagnostics Market?

Which region accounted for the largest share in Sepsis Diagnostics Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300